How often should methylprednisolone (Solumedrol) 125 mg IV be administered for transaminitis?

Methylprednisolone 125 mg IV Dosing for Transaminitis

For transaminitis, methylprednisolone 125 mg IV should NOT be given at all—this dose is too low for immune-mediated hepatitis requiring steroids, and transaminitis alone does not warrant corticosteroid therapy unless it represents grade ≥2 immune checkpoint inhibitor (ICI) hepatitis or severe autoimmune hepatitis.

Context-Dependent Dosing Algorithm

The appropriate frequency and indication for IV methylprednisolone in hepatitis depends entirely on the underlying cause and severity:

For ICI-Related Hepatitis (Most Relevant Guideline Context)

Grade 2 (AST/ALT 3-5x ULN):

• Oral prednisone 0.5-1.0 mg/kg/day is preferred over IV therapy 1
• For a 70 kg patient, this equals 35-70 mg daily orally
• IV methylprednisolone is NOT indicated at this grade

Grade 3 (AST/ALT 5-20x ULN):

• Methylprednisolone 1-2 mg/kg/day IV (70-140 mg for 70 kg patient) 1, 2
• This translates to approximately once daily dosing, not multiple times per day
• Continue until improvement, then taper over 4-6 weeks 1
• 125 mg falls within this range for an average-sized adult

Grade 4 (AST/ALT >20x ULN or hepatic decompensation):

• Methylprednisolone 2 mg/kg/day IV (140 mg for 70 kg patient) 1
• Again, once daily dosing
• Requires hospitalization and permanent ICI discontinuation 1

High-Dose "Pulse" Therapy (Different Context)

The FDA label describes a completely different dosing paradigm for acute, life-threatening conditions:

• 30 mg/kg IV over at least 30 minutes 3
• May repeat every 4-6 hours for up to 48-72 hours 3
• For a 70 kg patient, this would be 2,100 mg per dose—far exceeding your 125 mg question
• This regimen is used for conditions like spinal cord injury or severe neurologic emergencies, NOT routine hepatitis 3

Critical Answer to Your Specific Question

125 mg IV methylprednisolone does not fit standard dosing protocols for transaminitis:

• If treating grade 3 ICI hepatitis in a ~70-90 kg patient: Give once daily (1-2 mg/kg/day range) 1, 2
• If considering pulse-dose therapy: 125 mg is inadequate; would need 30 mg/kg every 4-6 hours 3
• If treating mild transaminitis without immune-mediated features: Steroids are contraindicated—investigate and remove hepatotoxins instead 1

Common Pitfalls

1. Steroids can CAUSE hepatotoxicity: High-dose IV methylprednisolone itself is a rare cause of drug-induced liver injury 4, 5, creating a paradoxical situation where the treatment worsens the problem

2. Dose matters for cardiac safety: Doses >500 mg given over <10 minutes risk cardiac arrhythmias and arrest 3—always infuse over at least 30 minutes for high doses

3. Grade 2 hepatitis uses ORAL steroids: Jumping to IV therapy at lower grades exposes patients to unnecessary risks 1

4. Response assessment timing: Expect improvement within 3-5 days; if no response, consider second-line immunosuppression (mycophenolate, tacrolimus, azathioprine) rather than escalating steroids 1

Practical Recommendation

Before giving any corticosteroids for transaminitis:

• Confirm the etiology (ICI-related vs. autoimmune vs. drug-induced vs. other)
• Grade the severity using AST/ALT and bilirubin levels
• Rule out viral hepatitis, biliary obstruction, and hepatic metastases 2
• For grade ≥3 ICI hepatitis: Start methylprednisolone 1-2 mg/kg IV once daily, which for most adults is 80-140 mg, making 125 mg a reasonable middle-ground dose given once per day 1, 2